A Cost That's Hard to (G)u(LP-1) Down
US$ 24.77
2023 international evidence-based guideline pcos glp-1 receptor agonist Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? | Journal of Endocrinological Investigation PDF) Recommendations from the 2023
Description
doi: 10.33549/physiolres.933822 24 HusainM.BirkenfeldA
PubMed 96
M., & Singh, R
These check-ups allow for early detection and intervention if any issues arise
Research funding from Boehringer Ingelheim
